Popular Articles

Pfizer's Sutent Is Recommended For Reimbursement For Gastrointestinal Stromal Tumor Patients By British Health Agency
Pfizer Inc said that the United Kingdom"s National Institute for Health and Clinical Excellence (NICE) has issued its final appraisal document (FAD) recommending reimbursement for Sutent (sunitinib malate) as a second-line treatment for patients with advanced gastrointestinal stromal tumor (GIST). This recommendation follows NICE"s recently published guidance recommending reimbursement for Sutent for the first-line treatment of advanced kidney cancer.
drugs without prescription
New Form Of Targeted Antibody Therapy Offers Further Hope To Patients With Incurable HER2-positive Breast Cancer
Final results from a phase II study presented at ASCO show that 25% of women with advanced HER2-positive breast cancer experienced significant shrinkage of their tumours, when treated with a first in class combination antibody called trastuzumab-DM1 (T-DM1). T-DM1 potentially represents another option for patients with metastatic disease, for which there is no cure.
News of the day
Investigating Why The Immune System Fails To Control Hepatitis C: Mass. General-Based Research Center
A research consortium based at Massachusetts General Hospital (MGH) has been awarded $15 million from the National Institute of Allergy and Infectious Diseases to investigate how the hepatitis C virus (HCV) resists suppression and clearance by the immune system. The five-year grant will support a Cooperative Center for Translational Research in Human Immunology, which also will focus on how some individuals successfully recover from HCV while the infection becomes chronic in most of those infected, with a special emphasis on immunological events in the liver as the site of HCV replication.
Mental Health

HIV Antibody Tests Unreliable For Early Infections In Teens

A previously healthy teenager shows up at the doctor"s office with a sore throat, fever, aches and general malaise. Routine blood tests are normal, an HIV test comes back negative, and the pediatrician sends the patient home with a diagnosis of acute viral infection. Two weeks later, the teen returns complaining of lingering symptoms and persistent high fevers. This time, a repeat HIV test comes back positive. What happened? The most commonly used rapid HIV test resulted in a false negative the first time around, which happens quite often during the earliest - and most contagious - stages of HIV infection, known as acute retroviral syndrome (ARS), explains Allison Agwu, M.D., a pediatric infectious disease specialist at Johns Hopkins Children"s Center. Because the rapid HIV screening tests are designed to detect antibodies to the virus, not the virus itself, such tests will only pick up infection in those who have developed antibodies, which most people don"t make until several weeks to several months after infection. Agwu cautions that "if a teen engages in risky behaviors and has symptoms of flu or mononucleosis, pediatricians should look further and not be lulled into a false sense of security by a negative rapid HIV test." Because an estimated 14 teenagers become infected with HIV every day in the United States, because ARS is both under-reported and underdiagnosed and because early infections are highly contagious, ARS should be on every pediatrician"s radar screen, Agwu says. To rule out HIV in teens deemed to be at high risk for sexually transmitted infections, Johns Hopkins HIV experts recommend the use of polymerase chain reaction (PCR) tests, which directly detect the virus" genetic markers, rather than antibodies to the virus. PCR tests, while more expensive than standard antibody tests, can detect the virus within two to three weeks after it enters the body. "Am I suggesting that every teen with flu-like symptoms should get a PCR? No. But I am suggesting that pediatricians take an extra minute to ask probing questions about risk behaviors and exposures in the last two months," Agwu says. "If the answers make you suspicious, then order the PCR." Consider ordering a PCR test if the patient is sexually active or has used injectible drugs and has two or more of the following symptoms: -- enlarged lymph nodes, a particularly telling sign -- night sweats, another key finding -- malaise, fatigue, headaches or a rash -- fever and chills -- persistent or recurrent sore throat and/or cough Johns Hopkins Medicine


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):